Speakers for this Event: Dr. med. Klaus Rose, MD, MS, Managing Director, klausrose Consulting William Sietsema, PhD, Vice President, Regulatory Consulting & Submissions, INC Research, and Adjunct Professor of Pharmaceutical Sciences, University of Cincinnati College of Pharmacy

The FDA and EMA's requirement of pediatric plans for new active ingredients, dosage forms, dosing regimens or routes of administration has made a thorough understanding of such regulations essential. In fact, without a Paediatric Investigational Plan, the EMA will no longer validate any submission.

INC Research is dedicated to helping companies navigate this challenging environment efficiently - so much so that we're holding a free webinar on the topic during which Klaus Rose and William Sietsema will share their advice on how to create insightful and innovative pediatric strategies that meet these stringent regulatory requirements.

Access to this archive is given on the understanding that you agree to the provision of your contact information to Xtalks sponsors and partners. Only primary contact information will be shared and this information will only be shared for the purposes of providing relevant offers. This registration form is an application only. Xtalks has the right to refuse access.

If you require help with your registration or have any questions you may contact Xtalks at: email: register@xtalks.com; phone: 416-977-6555, x 371.

By completing this registration form, you agree that the information you have provided is true and accurate.

(note: fields with marked "*" are required)